Printer Friendly
The Free Library
14,634,628 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

A Report on the Egyptian Pharmaceuticals and Healthcare Industry: Providing the Latest Forecasts, SWOT Analysis & Industry Developments.


DUBLIN Dublin, city, Republic of Ireland
Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River.
, Ireland Ireland, Irish Eire (âr`ə) [to it are related the poetic Erin and perhaps the Latin Hibernia], island, 32,598 sq mi (84,429 sq km), second largest of the British Isles.  -- Research and Markets (http://www.researchandmarkets.com/research/3f9611/egypt_pharmaceutic) has announced the addition of the "Egypt Pharmaceuticals and Healthcare Report Q3 2008" report to their offering.

BMI's Egypt Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Egypt's pharmaceuticals and healthcare industry.

Egypt's pharmaceutical market is a relatively unattractive prospect. Tough pricing regulation limit the market's potential, despite its size and government plans to roll out basic universal health coverage. In 2007, BMI BMI body mass index.

BMI
abbr.
body mass index


Body mass index (BMI)
A measurement that has replaced weight as the preferred determinant of obesity.
 estimates that drug expenditure was US$1.75bn. By 2012, we expect the market to be worth more than US$2.73bn. However, expectations that the Egyptian pound will strengthen further against the US dollar over the forecast period and significant price inflation serve to limit market growth in real terms. Local currency growth should average 5.5% a year between 2008 and 2012 - primarily driven by expanded basic government healthcare coverage.

Indeed, one of Egypt's leading drug-makers, the Egyptian International Pharmaceutical Industries Company (EIPICO), has decided to locate more production abroad to counter the effects of tough pricing regulation in its home market. EIPICO has a strong presence in Middle Eastern export markets, but has increasingly found that restrictive pricing in Egypt has translated to make for a tough export climate. Not only has a strong Egyptian pound squeezed profit margins, but countries that insist products are not priced higher than in their country of origin has made it difficult for EIPICO to continue its remarkable profitablity. As a consequence, EIPICO is exploring the possibility of building factories in Saudi Arabia Saudi Arabia (sä`dē ərā`bēə, sou`–, sô–), officially Kingdom of Saudi Arabia, kingdom (2005 est. pop.  and Algeria.

Unsurprisingly, Egypt performs poorly in BMI's Business Environment Ratings. For Q308, the country is again ranked in 11th place of the 13 Middle East and Africa (MEA MEA Multiple endocrine adenomatosis. See Multiple endocrine neoplasia. ) markets surveyed. The country scores particularly poorly in the market risks category due to its restrictive pricing policy. As foreseen fore·see  
tr.v. fore·saw , fore·seen , fore·see·ing, fore·sees
To see or know beforehand: foresaw the rapid increase in unemployment.
 by BMI, a bright spot for the country's regulatory environment came with the announcement that Egypt was downgraded from the USTR USTR United States Trade Representative
USTR United States Transuranium Registry (Richmond, Washington)
USTR Underground Storage Tank Regulation
 Special 301 report Priority Watch List to the Watch List in the organisation's 2008 report.

The government remains committed to its goal of achieving basic universal healthcare by 2010. The formidable task of healthcare system modernisation should prove a welcome boost for the healthcare industry as a whole. The medical device market, for which BMI provides five-year forecasts for the first time in Q308, is poised to benefit from improvements in the healthcare system. Indeed, we expect the medical device market to grow at close to 10% a year over the forecast period - significantly faster than the pharmaceutical market.

Key Topics Covered:

- Egypt Pharmaceuticals And Healthcare Industry SWOT

- Egypt Political SWOT

- Egypt Economic SWOT

- Egypt Business Environment SWOT

- Pharmaceutical Business Environment Ratings

- Limits To Potential Returns

- Risks To Realisation Of Returns

- Egypt - Market Summary

- Regulatory Regime

- Pricing Regime

- Reimbursement Reimbursement

Payment made to someone for out-of-pocket expenses has incurred.
 Regime

- Recent Pricing And Reimbursement Developments

- Industry Developments

- Health Profile

- Healthcare Sector

- Healthcare Insurance

- Pharmaceutical Sector

- Domestic Manufacturing

- Foreign Manufacturing Sector

- Retail Pharmacies This article is a list of major pharmacies (also known as chemists and drugstores) by country. Australia
Pharmacies in Australia are mostly independently-owned by pharmacists, often operated as franchises of retail brands offered by the three major
 

- Herbal herbal, early botanical book containing descriptions and illustrations of herbs and plants with their properties, chiefly those qualities that made them useful as medicines or condiments. Most of the herbals were written between c.1470 and c.  And OTC OTC

See: Over-the-counter.


OTC

See over-the-counter market (OTC).
 Medicine

- Research And Development Activity

- Medical Devices

- Industry Forecast Scenario

- Overall Market Forecast

- Key Growth Factors

- Patented Market Forecast

- Generics Drug Market Forecast

- OTC Market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange
over-the-counter market
 Forecast

- Pharmaceutical Export/Import Market Forecast

- Other Healthcare Data

- Key Risks To BMI Forecasts

- Competitive Landscape

- Company Monitors

- Multinational Profiles

- Domestic Companies

- BMI Forecast Modelling

For more information visit http://www.researchandmarkets.com/research/3f9611/egypt_pharmaceutic
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Aug 11, 2008
Words:558
Previous Article:'Cider/Perry in the United Kingdom' Identifies the Leading Companies, the Leading Brands and Offers Strategic Analysis of Key Factors Influencing the...
Next Article:IDEAS Helps Pocono Mountains Vacation Bureau Attain DMAI Accreditation.



Related Articles
Egypt's Drug Market Was Worth US$1.14bn in 2005 and Is One of the Largest in the Middle East and North Africa Region.
Switzerland Has an Advanced Pharmaceutical Market and Per-Capita Expenditure Is Among the Highest in the World at an Estimated US$743.4 in 2006.
Research and Markets: By 2012, BMI Forecasts That Egypt's Pharmaceuticals and Healthcare Market Will Top US$2.53Mn, up from Only around US$1.07Bn in...
US-Colombia FTA Should Bring Significant Changes to the Structure of Colombia's Pharmaceutical Market.
Ukraine Pharmaceuticals and Healthcare Report Q2 2008 Provides Competitive Intelligence on Ukraine's Pharmaceuticals and Healthcare Industry.(Report)
'Lithuania Pharmaceuticals and Healthcare Report Q2 2008' Reveals Forecasts for the Coming Five Years Annual Growth at Single-Digit Figures.
Israel Pharmaceuticals and Healthcare Report Q3 2008.
Chile Pharmaceuticals and Healthcare Report Q3 2008: Competitive Intelligence on Chile's Pharmaceuticals and Healthcare Industry.
This Essential and Comprehensive Report on the Australian Pharmaceuticals and Healthcare Industry is Now Available, Q3 2008.
Iran's Drug Expenditure to Grow by an Average Of 14.8% Year-On-Year to Reach IRR34, 494bn (US$3.52bn) By the End Of 2012.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles